Member Info for Mikey279

Sorry ignore me that excludes WRAP.... so at least £5.7m?

Significantly oversubscribed, from £4.5m to £5.2m......unicorn incoming

All IMO

Tempus going for it, nearly 17bn mcap

Time in the market> Timing the market

I'd give it a few months to see where we're at, wouldn't be surprised to see a slow and steady move to £1, no funding fears now and in bed with a now $16bn mcap company

AI, FDA approved, etc etc its the right place to be, just need patience

All IMO

Just a bit of churn but should fly in the coming days/weeks, its an incredible raise price and now the partnership is fully funded, tempus want to hit 1trillion.....its written

this would be £500m + if a USA equivalent company were at the same stage

All IMO

Fully expecting £100m mcap over the next few weeks

All IMO

If there were a uk NVIDIA equivalent to buy and hold for next 5-10years, this would be it

1.5bn signed with palantir today

All IMO

Just read the news...microsoft, nvidia.....31bn from usa into uk AI, and we're the only listed defence company?

crazy

Keep saying time and time again, this will be a billion £ company over the next few years

Did say it was good ;)

“and a premium of 39 per cent. to the Company's 90 day closing average share price, as of the last business day prior to this Announcement.”

It’s a good one for sure

Because the tempus news was not known, and it’s to progress the opportunity rather than a lights on and working cap as per usual AIM

“The agreement with Tempus is a significant milestone for the Company pursuant to which Tempus and Renalytix will collaborate with US health systems to make testing more available for providers to order within existing clinical workflows.

The Company will therefore use the net proceeds of the Fundraise to support the collaboration with Tempus and ensure the effective integration of kidneyintelX.dkd into Tempus' portfolio in the chronic kidney disease category.”

Plus a 39% premium to moving average (the usual metric)

Some shares do move after funding is confirmed too, it’s a fantastic price

All IMO

Bloody impressive

“and a premium of 39 per cent. to the Company's 90 day closing average share price, as of the last business day prior to this Announcement.”

Pretty strong raise considering we only broke 8p on Thursday should move massively now

All IMO

Yup would easily be at £500m across the pond on equivalent news and stage, but LSE means a discount

All IMO

Ok, revenue will come in time, tempus is targeting a trillion dollar market and we’re at the core of the ckd diabetic arm

A signed collab is a deal don’t nitpick

Yup the tempus COO message is a game changer, people are underestimating the magnitude of the deal and potential

That and look at the 3 year chart it’s on a full breakout, 1st target as high as 52p and then it’s straight to 80p and £1+ thereafter

All IMO

11.6 equivalent